Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hormone therapy in menopause: the plot thickens.

Andrew E Good1

  • 1Division of Medical Gynecology, Department of Obstetrics and Gynecology, Mayo Clinic Rochester, USA.

Minnesota Medicine
|February 15, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Human papillomavirus in vulvar vestibulitis syndrome.

The Journal of reproductive medicine·2007
Same author

Radiofrequency global endometrial ablation followed by hysteroscopic sterilization.

Journal of minimally invasive gynecology·2007
Same author

Long-term fracture risk among women with proven endometriosis.

Fertility and sterility·2006
Same author

Incidence and characterization of diagnosed endometriosis in a geographically defined population.

Fertility and sterility·2004
Same journal

Parent's hesitance about HPV Vaccine: Using the CASE approach to address their concerns.

Minnesota medicine·2021
Same journal

Vaping, lung injury, and mental health Minnesota 2018-2019.

Minnesota medicine·2021
Same journal

Characteristics of clinical extrapulmonary nontuberculous mycobacteria isolates in Minnesota, 2013-2017.

Minnesota medicine·2020
Same journal

Challenges for younger adults with diabetes.

Minnesota medicine·2020
Same journal

Telemedicine in Minnesota: A look at how four specialties are using it.

Minnesota medicine·2019
Same journal

The Doctor Will See You On Screen: Telemedicine offers convenient access to care, cost savings and the same quality as in-person visits-sometimes.

Minnesota medicine·2019
See all related articles

Conflicting evidence on hormone therapy (HT) safety and effectiveness creates uncertainty. New research suggests individual molecular responses explain varied outcomes, prompting a re-evaluation of HT treatments for women.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Women's Health Research

Background:

  • The Women's Health Initiative (WHI) study's trial termination has raised concerns regarding hormone therapy (HT) safety and efficacy.
  • Conflicting data on estrogen therapy (ET) and combined estrogen/progestin therapy (HT) challenges current clinical practice.

Purpose of the Study:

  • To explore the heterogeneity of molecular responses to hormone therapy.
  • To reconcile conflicting evidence from major studies like the Heart and Estrogen/Progestin Replacement Study (HERS) and WHI.
  • To discuss alternative therapeutic strategies for hormone replacement.

Main Methods:

  • Review of recent molecular investigations into estrogen receptor, genome, and cellular cofactor interactions.
  • Analysis of findings from primate studies explaining cardiovascular effects of HT.

Related Experiment Videos

  • Critical examination of key clinical trial data.

    • Main Results:

    • Evidence indicates heterogeneous molecular and individual responses to hormone therapy.
    • Primate studies offer potential explanations for adverse cardiovascular events observed in HT users.
    • Existing research methodologies may not fully capture individual patient variability.

    Conclusions:

    • Individualized treatment approaches are necessary for hormone therapy.
    • Lower-dose estrogen, transdermal delivery, and selective estrogen-receptor modulators are potential alternatives.
    • Reduced progestin use may mitigate risks associated with combined HT.